Published in J Pediatr on November 01, 2006
Predicting the clinical outcome of severe falciparum malaria in african children: findings from a large randomized trial. Clin Infect Dis (2012) 1.39
Assessment of severe malaria in a multicenter, phase III, RTS, S/AS01 malaria candidate vaccine trial: case definition, standardization of data collection and patient care. Malar J (2011) 1.11
Low tissue oxygen saturation at the end of early goal-directed therapy is associated with worse outcome in critically ill patients. Crit Care (2009) 1.08
Anaemia and blood transfusion in African children presenting to hospital with severe febrile illness. BMC Med (2015) 1.02
Predicting mortality for paediatric inpatients where malaria is uncommon. Arch Dis Child (2012) 1.00
Reduced cardiac output in imported Plasmodium falciparum malaria. Malar J (2011) 0.90
Clinical features and outcome in children with severe Plasmodium falciparum malaria: a meta-analysis. PLoS One (2014) 0.89
Nitroglycerin reverts clinical manifestations of poor peripheral perfusion in patients with circulatory shock. Crit Care (2014) 0.80
Ultrasonographic renal sizes, cortical thickness and volume in Nigerian children with acute falciparum malaria. Malar J (2013) 0.75
Clinical indicators for bacterial co-infection in Ghanaian children with P. falciparum infection. PLoS One (2015) 0.75
Factors influencing capillary refill time. J Pediatr (2007) 0.75
First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. N Engl J Med (2011) 10.79
Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet (2010) 8.52
A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. N Engl J Med (2012) 6.64
Genome-wide and fine-resolution association analysis of malaria in West Africa. Nat Genet (2009) 4.30
A randomized controlled trial of extended intermittent preventive antimalarial treatment in infants. Clin Infect Dis (2007) 3.38
Microevolution of extensively drug-resistant tuberculosis in Russia. Genome Res (2012) 2.81
Spatial variation of malaria incidence in young children from a geographically homogeneous area with high endemicity. J Infect Dis (2008) 2.68
Evaluating health research capacity building: an evidence-based tool. PLoS Med (2006) 2.58
Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial. Lancet Infect Dis (2011) 2.54
Standardized data collection for multi-center clinical studies of severe malaria in African children: establishing the SMAC network. Trans R Soc Trop Med Hyg (2006) 2.52
Autophagy gene variant IRGM -261T contributes to protection from tuberculosis caused by Mycobacterium tuberculosis but not by M. africanum strains. PLoS Pathog (2009) 2.35
Ethical data release in genome-wide association studies in developing countries. PLoS Med (2009) 2.23
A Multinational Trial of Prasugrel for Sickle Cell Vaso-Occlusive Events. N Engl J Med (2015) 2.03
Evaluation of a learner-designed course for teaching health research skills in Ghana. BMC Med Educ (2007) 2.02
Parasitological rebound effect and emergence of pyrimethamine resistance in Plasmodium falciparum after single-dose sulfadoxine-pyrimethamine. J Infect Dis (2005) 1.99
Hemoglobin variants and disease manifestations in severe falciparum malaria. JAMA (2007) 1.95
A prospective comparison of malaria with other severe diseases in African children: prognosis and optimization of management. Clin Infect Dis (2003) 1.93
Colchicine use in children and adolescents with familial Mediterranean fever: literature review and consensus statement. Pediatrics (2007) 1.68
Randomized controlled trial of RTS,S/AS02D and RTS,S/AS01E malaria candidate vaccines given according to different schedules in Ghanaian children. PLoS One (2009) 1.65
Indicators of sustainable capacity building for health research: analysis of four African case studies. Health Res Policy Syst (2011) 1.62
Malaria and intestinal helminth co-infection among pregnant women in Ghana: prevalence and risk factors. Am J Trop Med Hyg (2009) 1.52
Common variants at 11p13 are associated with susceptibility to tuberculosis. Nat Genet (2012) 1.52
Genome-wide association study indicates two novel resistance loci for severe malaria. Nature (2012) 1.52
Human genetic resistance to Onchocerca volvulus: evidence for linkage to chromosome 2p from an autosome-wide scan. J Infect Dis (2008) 1.49
ALOX5 variants associated with susceptibility to human pulmonary tuberculosis. Hum Mol Genet (2008) 1.43
Population pharmacokinetics of artesunate and dihydroartemisinin following intra-rectal dosing of artesunate in malaria patients. PLoS Med (2006) 1.42
Predicting the clinical outcome of severe falciparum malaria in african children: findings from a large randomized trial. Clin Infect Dis (2012) 1.39
Assessment of GFR by four methods in adults in Ashanti, Ghana: the need for an eGFR equation for lean African populations. Nephrol Dial Transplant (2010) 1.33
The prognostic value of measures of acid/base balance in pediatric falciparum malaria, compared with other clinical and laboratory parameters. Clin Infect Dis (2005) 1.30
MCP-1 promoter variant -362C associated with protection from pulmonary tuberculosis in Ghana, West Africa. Hum Mol Genet (2008) 1.28
Comparative evaluation of two rapid field tests for malaria diagnosis: Partec Rapid Malaria Test® and Binax Now® Malaria Rapid Diagnostic Test. BMC Infect Dis (2011) 1.25
Genomewide linkage analysis identifies polymorphism in the human interferon-gamma receptor affecting Helicobacter pylori infection. Am J Hum Genet (2003) 1.25
Novel TMC1 structural and splice variants associated with congenital nonsyndromic deafness in a Sudanese pedigree. Hum Mutat (2005) 1.24
Evaluation of the safety and immunogenicity of the RTS,S/AS01E malaria candidate vaccine when integrated in the expanded program of immunization. J Infect Dis (2010) 1.21
Haematological and biochemical reference values for healthy adults in the middle belt of Ghana. PLoS One (2012) 1.20
Hemoglobin estimation by the HemoCue® portable hemoglobin photometer in a resource poor setting. BMC Clin Pathol (2011) 1.16
Exploring the relationship between chronic undernutrition and asymptomatic malaria in Ghanaian children. Malar J (2010) 1.15
Genome-wide linkage analysis of malaria infection intensity and mild disease. PLoS Genet (2007) 1.13
Mycobacterium tuberculosis drug resistance, Ghana. Emerg Infect Dis (2006) 1.12
Pulmonary tuberculosis: virulence of Mycobacterium africanum and relevance in HIV co-infection. Tuberculosis (Edinb) (2008) 1.12
Variant G57E of mannose binding lectin associated with protection against tuberculosis caused by Mycobacterium africanum but not by M. tuberculosis. PLoS One (2011) 1.11
Assessment of severe malaria in a multicenter, phase III, RTS, S/AS01 malaria candidate vaccine trial: case definition, standardization of data collection and patient care. Malar J (2011) 1.11
Therapeutic and prophylactic effect of intermittent preventive anti-malarial treatment in infants (IPTi) from Ghana and Gabon. Malar J (2008) 1.10
Analysis of association of the TIRAP (MAL) S180L variant and tuberculosis in three populations. Nat Genet (2008) 1.10
IL10 haplotype associated with tuberculin skin test response but not with pulmonary TB. PLoS One (2009) 1.09
Prognostic value of circulating pigmented cells in African children with malaria. J Infect Dis (2009) 1.09
The Lambaréné Organ Dysfunction Score (LODS) is a simple clinical predictor of fatal malaria in African children. J Infect Dis (2009) 1.07
Assessing the relationship between socioeconomic conditions and urban environmental quality in Accra, Ghana. Int J Environ Res Public Health (2010) 1.07
A combined analysis of immunogenicity, antibody kinetics and vaccine efficacy from phase 2 trials of the RTS,S malaria vaccine. BMC Med (2014) 1.07
High prevalence of markers for sulfadoxine and pyrimethamine resistance in Plasmodium falciparum in the absence of drug pressure in the Ashanti region of Ghana. Antimicrob Agents Chemother (2005) 1.06
Malaria incidence and efficacy of intermittent preventive treatment in infants (IPTi). Malar J (2007) 1.06
Population kinetics, efficacy, and safety of dichloroacetate for lactic acidosis due to severe malaria in children. J Clin Pharmacol (2003) 1.05
T cell responses to the RTS,S/AS01(E) and RTS,S/AS02(D) malaria candidate vaccines administered according to different schedules to Ghanaian children. PLoS One (2011) 1.04
Giardia lamblia: a major parasitic cause of childhood diarrhoea in patients attending a district hospital in Ghana. Parasit Vectors (2011) 1.03
Rural and semi-urban differences in salt intake, and its dietary sources, in Ashanti, West Africa. Ethn Dis (2005) 1.01
Nephrogenic diabetes insipidus caused by mutation of Tyr205: a key residue of V2 vasopressin receptor function. Hum Mutat (2005) 1.01
Availability and price of malaria rapid diagnostic tests in the public and private health sectors in 2011: results from 10 nationally representative cross-sectional retail surveys. Trop Med Int Health (2015) 1.00
Comparison of the novel Partec rapid malaria test to the conventional Giemsa stain and the gold standard real-time PCR. J Clin Microbiol (2010) 0.98
A comparison of women with induced abortion, spontaneous abortion and ectopic pregnancy in Ghana. Contraception (2010) 0.98